Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes (Q40652278)

22 September 2017

title

Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes (English)

1 reference

22 September 2017

Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes (English)

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

27 December 2023

0 references

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

27 December 2023

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

27 December 2023

7

Kenneth C Anderson

1 reference

22 September 2017

5

Paul Richardson

1 reference

22 September 2017

4

Noopur Raje

1 reference

22 September 2017

6

Dharminder Chauhan

1 reference

22 September 2017

2

Teru Hideshima

1 reference

22 September 2017

3

Masaharu Akiyama

1 reference

22 September 2017

Toshiaki Hayashi

1

1 reference

22 September 2017

Paul Richardson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714512

27 December 2023

language of work or name

English

0 references

publication date

24 April 2003

1 reference

full work available at URL

22 September 2017

published in

Blood

1 reference

22 September 2017

volume

102

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

1435-1442

1 reference

Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma

22 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect

27 December 2023

2

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells and the control of immunity

27 December 2023

4

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

27 December 2023

6

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

27 December 2023

7

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

27 December 2023

8

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo

27 December 2023

9

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

27 December 2023

10

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

27 December 2023

11

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin

27 December 2023

13

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

27 December 2023

15

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

27 December 2023

16

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma

27 December 2023

18

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

27 December 2023

19

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

27 December 2023

20

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma

27 December 2023

23

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

27 December 2023

26

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Thalidomide is an inhibitor of angiogenesis

27 December 2023

27

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

27 December 2023

30

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

27 December 2023

31

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Apaf-1/cytochrome c-independent and Smac-dependent induction of apoptosis in multiple myeloma (MM) cells

27 December 2023

32

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

27 December 2023

33

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma

27 December 2023

34

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

27 December 2023

36

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

27 December 2023

37

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

27 December 2023

39

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Optimizing dendritic cell-based immunotherapy in multiple myeloma

27 December 2023

40

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

27 December 2023

41

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells

27 December 2023

42

1 reference

https://api.crossref.org/works/10.1182/BLOOD-2002-09-2828

27 December 2023

Identifiers

1 reference

22 September 2017

1 reference